Innocenti F - Search Results

1

Identification of a Genomic Region between SLC29A1 and HSP90AB1 Associated with Risk of Bevacizumab-Induced Hypertension: CALGB 80405 (Alliance).

Li M, Mulkey F, Jiang C, O'Neil BH, Schneider BP, Shen F, Friedman PN, Momozawa Y, Kubo M, Niedzwiecki D, Hochster HS, Lenz HJ, Atkins JN, Rugo HS, Halabi S, Kelly WK, McLeod HL, Innocenti F, Ratain MJ, Venook AP, Owzar K, Kroetz DL. Li M, et al. Among authors: innocenti f. Clin Cancer Res. 2018 Oct 1;24(19):4734-4744. doi: 10.1158/1078-0432.CCR-17-1523. Epub 2018 Jun 5. Clin Cancer Res. 2018. PMID: 29871907 Free PMC article.

2

Flavopiridol metabolism in cancer patients is associated with the occurrence of diarrhea.

Innocenti F, Stadler WM, Iyer L, Ramírez J, Vokes EE, Ratain MJ. Innocenti F, et al. Clin Cancer Res. 2000 Sep;6(9):3400-5. Clin Cancer Res. 2000. PMID: 10999721

3

Pharmacogenetics: a tool for individualizing antineoplastic therapy.

Innocenti F, Iyer L, Ratain MJ. Innocenti F, et al. Clin Pharmacokinet. 2000 Nov;39(5):315-25. doi: 10.2165/00003088-200039050-00001. Clin Pharmacokinet. 2000. PMID: 11108431 Review.

4

Pharmacogenetics of anticancer agents: lessons from amonafide and irinotecan.

Innocenti F, Iyer L, Ratain MJ. Innocenti F, et al. Drug Metab Dispos. 2001 Apr;29(4 Pt 2):596-600. Drug Metab Dispos. 2001. PMID: 11259359

5

Epirubicin glucuronidation is catalyzed by human UDP-glucuronosyltransferase 2B7.

Innocenti F, Iyer L, Ramírez J, Green MD, Ratain MJ. Innocenti F, et al. Drug Metab Dispos. 2001 May;29(5):686-92. Drug Metab Dispos. 2001. PMID: 11302935

6

Update on pharmacogenetics in cancer chemotherapy.

Innocenti F, Ratain MJ. Innocenti F, et al. Eur J Cancer. 2002 Mar;38(5):639-44. doi: 10.1016/s0959-8049(01)00434-8. Eur J Cancer. 2002. PMID: 11916544 Review.

7

Correspondence re: Raida, M. et al., prevalence of a common point mutation in the dihydropyrimidine dehydrogenase (DPD) gene within the 5'-splice donor site of intron 14 in patients with severe 5-fluorouracil (5-FU)-related toxicity compared with controls.

Innocenti F, Ratain MJ. Innocenti F, et al. Clin Cancer Res. 2002 May;8(5):1314; author reply 1315-6. Clin Cancer Res. 2002. PMID: 12006555 No abstract available.

8

In vitro characterization of hepatic flavopiridol metabolism using human liver microsomes and recombinant UGT enzymes.

Ramírez J, Iyer L, Journault K, Bélanger P, Innocenti F, Ratain MJ, Guillemette C. Ramírez J, et al. Among authors: innocenti f. Pharm Res. 2002 May;19(5):588-94. doi: 10.1023/a:1015341726183. Pharm Res. 2002. PMID: 12069159

9

Haplotype structure of the UDP-glucuronosyltransferase 1A1 promoter in different ethnic groups.

Innocenti F, Grimsley C, Das S, Ramírez J, Cheng C, Kuttab-Boulos H, Ratain MJ, Di Rienzo A. Innocenti F, et al. Pharmacogenetics. 2002 Dec;12(9):725-33. doi: 10.1097/00008571-200212000-00006. Pharmacogenetics. 2002. PMID: 12464801

10

Pharmacogenetics in cancer treatment.

Nagasubramanian R, Innocenti F, Ratain MJ. Nagasubramanian R, et al. Among authors: innocenti f. Annu Rev Med. 2003;54:437-52. doi: 10.1146/annurev.med.54.101601.152352. Epub 2001 Dec 3. Annu Rev Med. 2003. PMID: 12525681 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

416 results

Search Page